DOTA-NAPamide

• Description :

  DOTA-NAPamide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].

• UNSPSC :

  12352005

• Target :

  Radionuclide-Drug Conjugates (RDCs)

• Type :

  Peptides

• Related Pathways :

  Antibody-drug Conjugate/ADC Related

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/dota-napamide.html

• Smiles :

  CCCC[C@H](NC(C)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC1=CN=CN1)C(N[C@H](CC2=CC=CC=C2)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(NCC(N[C@H](C(N)=O)CCCCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)=O)=O)=O

• Molecular Formula :

  C68H100N20O18

• Molecular Weight :

  1485.64

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  No Development Reported

• CAS Number :

  [935886-72-9]